Steroid metabolome analysis reveals that prostate cancer has potent 5[alpha]-reductase, 3[alpha]- and 17[beta]-hydroxysteroid dehydrogenase activities, but lacks 17-hydroxylase/17,20-lyase

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)